DE602007003348D1 - Muscarin-agonisten zur behandlung von impulskontrollstörungen - Google Patents
Muscarin-agonisten zur behandlung von impulskontrollstörungenInfo
- Publication number
- DE602007003348D1 DE602007003348D1 DE602007003348T DE602007003348T DE602007003348D1 DE 602007003348 D1 DE602007003348 D1 DE 602007003348D1 DE 602007003348 T DE602007003348 T DE 602007003348T DE 602007003348 T DE602007003348 T DE 602007003348T DE 602007003348 D1 DE602007003348 D1 DE 602007003348D1
- Authority
- DE
- Germany
- Prior art keywords
- impulse control
- control disorders
- disorder
- agonists
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79735506P | 2006-05-04 | 2006-05-04 | |
EP06113476 | 2006-05-04 | ||
PCT/EP2007/053934 WO2007128674A2 (en) | 2006-05-04 | 2007-04-23 | Muscarinic agonists to treat impulse control disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602007003348D1 true DE602007003348D1 (de) | 2009-12-31 |
Family
ID=38544084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602007003348T Active DE602007003348D1 (de) | 2006-05-04 | 2007-04-23 | Muscarin-agonisten zur behandlung von impulskontrollstörungen |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP2023909B1 (de) |
JP (1) | JP2010501471A (de) |
KR (1) | KR20090013815A (de) |
AT (1) | ATE448778T1 (de) |
AU (1) | AU2007247231B2 (de) |
CA (1) | CA2649917A1 (de) |
DE (1) | DE602007003348D1 (de) |
EA (1) | EA014915B1 (de) |
ES (1) | ES2336275T3 (de) |
IL (1) | IL194778A0 (de) |
PL (1) | PL2023909T3 (de) |
WO (1) | WO2007128674A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011520905A (ja) * | 2008-05-15 | 2011-07-21 | ザ・ユニバーシティ・オブ・トレド | 向知性剤としてのムスカリンアゴニスト |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
WO2011011060A1 (en) * | 2009-07-22 | 2011-01-27 | Puretech Ventures | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
KR101613245B1 (ko) | 2015-04-27 | 2016-04-18 | 주식회사 대웅제약 | 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
CA3180743A1 (en) | 2018-09-28 | 2020-04-02 | Karuna Therapeutics, Inc. | Composition comprising xanomeline and trospium for treating disorders ameliorated by muscarinic receptor activation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE922270A1 (en) * | 1991-07-26 | 1993-01-27 | Akzo Nv | Pyrazole derivatives |
US6117890A (en) * | 1996-08-01 | 2000-09-12 | Eli Lilly And Company | Method for treating bipolar disorder |
AU2002245486B2 (en) * | 2001-02-23 | 2006-11-16 | Ucb Pharma, S.A. | Treatment of tics, tremors and related disorders |
TW200528455A (en) * | 2003-12-19 | 2005-09-01 | Bristol Myers Squibb Co | Azabicyclic heterocycles as cannabinoid receptor modulators |
JP2008509147A (ja) * | 2004-08-05 | 2008-03-27 | アカディア ファーマシューティカルズ,インコーポレーテッド | ヒト神経精神病を治療するためのn−デスメチルクロザピンの使用 |
GB0428170D0 (en) * | 2004-12-23 | 2005-01-26 | Biopartners Ltd | Mono and Combination Therapy |
-
2007
- 2007-04-23 EP EP07728391A patent/EP2023909B1/de not_active Not-in-force
- 2007-04-23 ES ES07728391T patent/ES2336275T3/es active Active
- 2007-04-23 PL PL07728391T patent/PL2023909T3/pl unknown
- 2007-04-23 WO PCT/EP2007/053934 patent/WO2007128674A2/en active Application Filing
- 2007-04-23 AU AU2007247231A patent/AU2007247231B2/en not_active Expired - Fee Related
- 2007-04-23 KR KR1020087029621A patent/KR20090013815A/ko not_active Application Discontinuation
- 2007-04-23 CA CA002649917A patent/CA2649917A1/en not_active Abandoned
- 2007-04-23 DE DE602007003348T patent/DE602007003348D1/de active Active
- 2007-04-23 AT AT07728391T patent/ATE448778T1/de not_active IP Right Cessation
- 2007-04-23 JP JP2009508308A patent/JP2010501471A/ja active Pending
- 2007-04-23 EA EA200870498A patent/EA014915B1/ru not_active IP Right Cessation
-
2008
- 2008-10-22 IL IL194778A patent/IL194778A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010501471A (ja) | 2010-01-21 |
ATE448778T1 (de) | 2009-12-15 |
AU2007247231A1 (en) | 2007-11-15 |
AU2007247231B2 (en) | 2012-05-31 |
EP2023909B1 (de) | 2009-11-18 |
WO2007128674A2 (en) | 2007-11-15 |
WO2007128674A3 (en) | 2008-04-03 |
IL194778A0 (en) | 2009-08-03 |
PL2023909T3 (pl) | 2010-04-30 |
EA200870498A1 (ru) | 2009-04-28 |
CA2649917A1 (en) | 2007-11-15 |
EA014915B1 (ru) | 2011-02-28 |
ES2336275T3 (es) | 2010-04-09 |
EP2023909A2 (de) | 2009-02-18 |
KR20090013815A (ko) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE448778T1 (de) | Muscarin-agonisten zur behandlung von impulskontrollstörungen | |
HK1225642A1 (zh) | 用於治療假性延髓反應、神經性疾病、頑固性及慢性疼痛以及腦損傷的嗎啡喃化合物和抗抑鬱劑組合 | |
EA200800157A1 (ru) | Антагонисты npy, способ их получения и применение | |
IL197118A0 (en) | Ultrasonic treatment of glaucoma | |
WO2006099541A3 (en) | Therapeutic wound care product | |
FR2897061B1 (fr) | Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique. | |
WO2010030813A3 (en) | Methods for inhibiting ocular angiogenesis | |
PT2878297T (pt) | Medicamentos para o tratamento ou prevenção de doenças fibróticas | |
ATE528002T1 (de) | Pyridoncarboxamidderivate zur behandlung hyperproliferativer und angiogenese-vermittelter leiden | |
WO2007003411A3 (en) | Kinin antagonists for treating bladder dysfunction | |
EP2374455A3 (de) | Modulatoren von muskarinischen Rezeptoren | |
FI20041152A (fi) | Kemiallisen massan ksylanaasikäsittely | |
WO2006058016A3 (en) | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
SI2024368T1 (sl) | Derivati 6,7,8,9-tetrahidro-5h-pirimido(4,5-d)azepin-4-il)-amina kot modulatorji trpv 1 za zdravljenje boleäśine | |
DE60313478D1 (de) | N-substituierte hydromorphone und ihre anwendung | |
IL184124A0 (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
PT2007942E (pt) | Tratamento de têxteis num passo | |
FR2927330B1 (fr) | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii | |
FR2904827B1 (fr) | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antiganistes des recepteurs a l'urotensine ii | |
NZ595545A (en) | Compositions and methods for prophylaxis and treatment of addictions | |
EP1749000A4 (de) | Bicyclische substituierte triazole als ppar-modulatoren und verfahren zu deren herstellung | |
CA2474510A1 (en) | Fused tricyclic heterocycles useful for treating hyper-proliferative disorders | |
GB0413068D0 (en) | Treatment of pulp | |
CL2007003836A1 (es) | Uso de compuestos derivados de isosorbide en la prevencion y/o tratamiento de enfermedades oftalmologicas mediadas por hipertension ocular, tales como glaucoma. | |
WO2007039123A3 (en) | Combination therapy comprising an nk-3 antagonist and an antipsychotic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |